by Jordana Choucair | Sep 29, 2022 | Opioid/Substance Use Disorders
Yesterday, in recognition of National Recovery Month, the U.S. Congress Joint Economic Committee (JEC) released a new analysis that finds the opioid epidemic cost the U.S. a record of nearly $1.5 trillion in 2020. The Centers for Disease Control and Prevention (CDC)...
by Jordana Choucair | Sep 26, 2022 | Opioid/Substance Use Disorders
A FAIR Health analysis – released to Axios one day in advance of publication – shows the rising burden of substance use across the U.S. According to the study of private insurance claims, 42 states saw an increase in the proportion of patients with opioid and...
by Jordana Choucair | Sep 26, 2022 | Opioid/Substance Use Disorders
President Biden announced that his administration will distribute $1.5 billion to states and territories to fund responses to opioid overdoses and support recovery. The U.S. Department of Health and Human Services (HHS) will disseminate the funding through the...
by Jordana Choucair | Sep 23, 2022 | Opioid/Substance Use Disorders
The FDA released final guidance loosening requirements for distributing naloxone, an opioid overdose medication. The agency said that it will not enforce certain Drug Supply Chain Security Act requirements for public health programs that distribute naloxone to...
by Jordana Choucair | Sep 21, 2022 | Opioid/Substance Use Disorders
West Virginia Attorney General Patrick Morrisey announced that the state reached a $147 million settlement with CVS and Walmart about the pharmacies alleged roles in the opioid epidemic. The state alleged the pharmacies failed to maintain effective controls as a...
by Jordana Choucair | Sep 20, 2022 | Opioid/Substance Use Disorders
The Duke-Margolis Center for Health Policy released a new brief exploring challenges and opportunities for integrating Substance Use Disorder (SUD) treatment into Community Health Centers (CHCs). Drawing on the experiences of CHC leadership and national experts –...
Recent Comments